Tavistock

The publication this week of the Cass Review into gender-identity services for young people marks a welcome return to reason in an area of medicine which for the past few years has been driven by identity politics. No one is denying that there are those who deserve psychological – and in some cases physical – help to cope with their condition. But the explosion in the number of children treated on the NHS for gender-identity issues (and in many cases being given powerful drugs with severe side effects) should have set alarm bells ringing long before it did. The NHS first set up its Gender Identity Development Service (GIDS) at the Tavistock Clinic in 1989, and for the first two decades of its existence it was a small outfit with a low profile.

"In July, Britain’s National Health Service announced a major revamp of its gender identity services for young people. The famed Tavistock clinic — officially named the Gender Identity Development Service, operated by the Tavistock and Portman Trust and a flashpoint for the country’s debate about gender, trans issues and hormone treatments — would be shuttered. As the New York Times reported, it would be replaced by “a more distributed and comprehensive network of medical care for adolescents seeking hormones and other gender treatments.” This outcome was strongly hinted at in the interim report of the Cass Review, an ongoing investigation into gender identity services for children, headed by the accomplished pediatrics expert Hilary Cass.